AAV2-mediated transfer of the human aquaporin-1 cDNA restores fluid secretion from irradiated miniature pig parotid glands

[1]  N. Slevin,et al.  Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy. , 2009, European journal of cancer.

[2]  J. Chiorini,et al.  Long‐term transduction of miniature pig parotid glands using serotype 2 adeno‐associated viral vectors , 2009, The journal of gene medicine.

[3]  Johannes A Langendijk,et al.  Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. , 2009, International journal of radiation oncology, biology, physics.

[4]  Hong Wang,et al.  Mitochondrial Targeting of a Catalase Transgene Product by Plasmid Liposomes Increases Radioresistance In Vitro and In Vivo , 2009, Radiation research.

[5]  N. Aaronson,et al.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  James B. Mitchell,et al.  Prevention of irradiation-induced salivary hypofunction by microvessel protection in mouse salivary glands. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  B. Baum,et al.  Gender differences in serotype 2 adeno-associated virus biodistribution after administration to rodent salivary glands. , 2007, Human gene therapy.

[8]  James B. Mitchell,et al.  Differential Radiation Protection of Salivary Glands versus Tumor by Tempol with Accompanying Tissue Assessment of Tempol by Magnetic Resonance Imaging , 2007, Clinical Cancer Research.

[9]  T. Begenisich,et al.  Functional and molecular characterization of the fluid secretion mechanism in human parotid acinar cells. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  J. Chiorini,et al.  Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates. , 2007, Human gene therapy.

[11]  J. Chiorini,et al.  Toxicity and biodistribution of a first-generation recombinant adenoviral vector, encoding aquaporin-1, after retroductal delivery to a single rat submandibular gland. , 2006, Human gene therapy.

[12]  B. Baum,et al.  Enhanced transduction of mouse salivary glands with AAV5-based vectors , 2006, Gene Therapy.

[13]  J. Rasko,et al.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.

[14]  B. Baum,et al.  Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. , 2005, International journal of radiation oncology, biology, physics.

[15]  P. Tak,et al.  Immune responses following salivary gland administration of recombinant adeno‐associated virus serotype 2 vectors , 2005, The journal of gene medicine.

[16]  B. Baum,et al.  Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  I. Bossis,et al.  Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Baum,et al.  Developing a convenient large animal model for gene transfer to salivary glands in vivo , 2004, The journal of gene medicine.

[19]  D. Brizel,et al.  Does amifostine have a role in chemoradiation treatment? , 2003, The Lancet. Oncology.

[20]  A. Vissink,et al.  Prevention and treatment of the consequences of head and neck radiotherapy. , 2003, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[21]  R. Wait,et al.  A modified silver staining protocol for visualization of proteins compatible with matrix‐assisted laser desorption/ionization and electrospray ionization‐ mass spectrometry , 2000, Electrophoresis.

[22]  R. Kotin,et al.  Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo. , 1998, Human gene therapy.

[23]  S. Yu,et al.  Repetitive adenovirus administration to the parotid gland: role of immunological barriers and induction of oral tolerance. , 1998, Human gene therapy.

[24]  P. Agre,et al.  Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[26]  L. Tabak,et al.  Examination of rat salivary glands for the presence of the aquaporin CHIP , 1994, Pflügers Archiv.

[27]  P. Agre,et al.  Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. D. Caballero,et al.  Oral sequelae of head and neck radiotherapy , 2011 .

[29]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[30]  B. Baum,et al.  AAV5-mediated gene transfer to the parotid glands of non-human primates , 2010, Gene Therapy.

[31]  G. Illei,et al.  Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction. , 2009, Handbook of experimental pharmacology.

[32]  J. E. Melvin,et al.  The salivary gland fluid secretion mechanism. , 2009, The journal of medical investigation : JMI.